| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111348 synergistic mixture of [1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-(1,3,3-trimethyl-6-aza-bicyclo[3.2.1]oct-6-yl)-methanone and hypotensive agent; insulin resistance, dyslipidemia, obesity |
| 05/25/2006 | US20060111341 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111292 Using gene-regulatory peptide |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111286 Method of modulating endothelial cell activity |
| 05/25/2006 | US20060111284 Method for treating cancer |
| 05/25/2006 | US20060110492 Preparation and food product comprising an active phytase |
| 05/25/2006 | US20060110384 Novel proteins and use thereof |
| 05/25/2006 | US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 05/24/2006 | EP1659172A1 Adipogenic differentiation of human mesenchymal stem cells |
| 05/24/2006 | EP1659123A1 Bicyclic pyrazole derivative |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659114A2 Process for the preparation of bicyclo[3.2.1]octane fused with quinazoline derivatives |
| 05/24/2006 | EP1658852A1 Oral pharmaceutical preparation containing ibandronat |
| 05/24/2006 | EP1658843A1 Use of long chain alcohols for the treatment of hypercholesterolaemia |
| 05/24/2006 | EP1658292A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 05/24/2006 | EP1658288A1 2-amino-5-benzoylthiazole npy antagonists |
| 05/24/2006 | EP1658260A1 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes |
| 05/24/2006 | EP1658079A1 Multivitamin syrup for children or young adults |
| 05/24/2006 | EP1658069A1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity |
| 05/24/2006 | EP1658067A1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 05/24/2006 | EP1658059A1 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
| 05/24/2006 | EP1585513B1 Use of docosahexanoic acid as active substance for the treatment of lipodystrophy |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1340504B1 Remedies for diabetes |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1274322B1 Composition comprising free amino acids |
| 05/24/2006 | EP1259520B1 Novel purines |
| 05/24/2006 | EP1063971A4 Controlled release oral tablet having a unitary core |
| 05/24/2006 | EP1061887B1 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 05/24/2006 | EP1002075B1 Adipocyte-specific protein homologs |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | DE102004055858A1 Verwendung von langkettigen Alkoholen zur effektiven Senkung erhöhter Cholesterinspiegel Use of long chain alcohols for effectively lowering elevated cholesterol |
| 05/24/2006 | CN1777608A Fused pyrimidine derivative |
| 05/24/2006 | CN1777605A Cannabined receptor ligands and uses thereof |
| 05/24/2006 | CN1777581A Remedy for diabetes |
| 05/24/2006 | CN1777428A Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 05/24/2006 | CN1777420A Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 05/24/2006 | CN1777418A Composition for slimming |
| 05/24/2006 | CN1777417A Use of a pparalpha agonist and metformin for decreasing the serum triglycerides |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775762A Liyustrazine acyl piperazine derivative, and its preparing method and medicinal composition and use |
| 05/24/2006 | CN1775289A Multi vitamin oral disintegrating tablet formulation and its preparing method |
| 05/24/2006 | CN1775277A Natural medicine composition for preventing and treating metabolic syndrome |
| 05/24/2006 | CN1775262A Guifu-Dihuang preparation and preparing method |
| 05/24/2006 | CN1775237A Production process for extracting Chinese-date essence from chinese date |
| 05/24/2006 | CN1775111A Pumpkin juice for diabetes patients |
| 05/24/2006 | CN1257259C Formulation for health-care red rice wine |
| 05/24/2006 | CN1257176C Application of 2,3,5,4'-tetrahydroxy diphenyl ethylene-2-1-beta-D-glucoside for preparation of drug reducing blood fat |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/24/2006 | CN1256984C Isulin solid granular, its preparation method and its use in preparing medicine for treating diabetes |
| 05/24/2006 | CN1256972C Medicine for treating diabetes |
| 05/24/2006 | CN1256957C Compound Chinese medicine prepn containing white mulberry bark and bitter buckwheat with hypoglycemic effect and its preparation process |
| 05/24/2006 | CN1256952C Sea dog meat and bone meal capsule, preparation method and usage |
| 05/24/2006 | CN1256950C Use of sea dog soft capsule in preparing health products for regulating blood fat |
| 05/24/2006 | CN1256943C Stable ascorbic acid inorganic salt liquid composition, its preparation method and applications |
| 05/24/2006 | CN1256941C Body fat level controllers |
| 05/23/2006 | US7049445 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 05/23/2006 | US7049416 Phosophoinositoglycan binding proteins |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049345 Fat-binding polymers |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049304 Aryl boronic acids for treating obesity |
| 05/23/2006 | US7049294 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 05/23/2006 | US7049292 Administering a peptide having a sequence of QPLALEGSLQK in combination with another polypeptide to treat insulin dependent diabetes mellitus (IDDM or Type 1 diabetes) |
| 05/23/2006 | US7049288 Administering to a host for inhibiting absorption of dietary starch, an effective amount of a phaseolamin and vanadium (vanadium bound by a glycoprotein matrix which is produced by Lactobacillus acidophilus and Saccharomyces cervisiae) |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049283 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 05/23/2006 | US7049079 Coupling factor 6 inhibitor and potentiator and use thereof |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048914 Placental alkaline phosphatase to control diabetes |
| 05/23/2006 | US7048908 Particles for inhalation having sustained release properties |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/18/2006 | WO2006053217A1 Weight loss composition and method |
| 05/18/2006 | WO2006053109A1 Heteroaryl compounds |
| 05/18/2006 | WO2006053043A2 Methods of treating diabetes mellitus |
| 05/18/2006 | WO2006052722A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 05/18/2006 | WO2006052569A1 Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists |
| 05/18/2006 | WO2006052031A1 Protein hydrolysate with antidiabetic effect |
| 05/18/2006 | WO2006052007A1 Glycemic controlling agent |
| 05/18/2006 | WO2006051980A1 Packed beverage for lipid combustion promotion |
| 05/18/2006 | WO2006051951A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR |
| 05/18/2006 | WO2006051851A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051662A1 Thiazole derivative |